IBRN ETF largest holding is ALKS:IE at 4.69% as of Jun 30, 2026
iShares Neuroscience and Healthcare ETF
ALKS:IE is IBRN's largest holding at 4.69% of the fund as of Jun 30, 2026. IBRN is iShares Neuroscience and Healthcare ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Share chg | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|
| 1 | — | Alkermes Plc. Ordinary SharesHealth Care · Pharmaceuticals | 4.69% | 4.7% | 4,978 | $274.5K | - | Health Care | Pharmaceuticals |
| 2 | S | Scholar Rock Holding Corp | 4.55% | 9.2% | 4,810 | $266.3K | - | - | - |
| Share changes, sector and industry · Pro | |||||||||
| 3 | P | Praxis Precision Medicines Inc | 4.47% | 13.7% | 835 | $261.8K | |||
| 4 | P | Ptc Therapeutics Inc | 4.38% | 18.1% | 3,002 | $256.5K | |||
| 5 | A | Arrowhead Pharmaceuticals Inc | 4.31% | 22.4% | 2,915 | $252.3K | |||
| 6 | X | Xenon Pharmaceuticals Inc. Common Shares | 4.26% | 26.7% | 4,118 | $249.3K | |||
| 7 | A | Acadia Pharmaceuticals Inc | 4.23% | 30.9% | 9,613 | $247.7K | |||
| 8 | D | Dianthus Therapeutics Inc | 4.22% | 35.1% | 2,646 | $247.0K | |||
| 9 | B | Biogen Inc. | 3.88% | 39.0% | 1,091 | $227.4K | |||
| 10 | N | Neurocrine Biosciences Inc | 3.86% | 42.9% | 1,300 | $226.3K | |||
| 11 | A | Axsome Therapeutics Inc | 3.80% | 46.6% | 917 | $222.5K | |||
| 12 | — | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | 3.74% | 50.4% | 239 | $219.1K | |||
| 13 | D | Denali Therapeutics Inc | 3.72% | 54.1% | 8,462 | $217.8K | |||
| 14 | C | Carver Bancorp Inc. | 3.41% | 57.5% | 6,346 | $199.9K | |||
| 15 | Debt | Blackrock Cash Funds: Treasury, Sl Agency Shares | 3.39% | 60.9% | 198,626 | $198.6K | |||
| 16 | E | Edgewise Therapeutics Inc. | 3.05% | 64.0% | 4,463 | $179.0K | |||
| 17 | D | Dyne Therapeutics Inc | 2.93% | 66.9% | 7,509 | $171.5K | |||
| 18 | S | Supernus Pharmaceuticals Inc | 2.50% | 69.4% | 3,096 | $146.3K | |||
| 19 | A | Axogen Inc | 2.31% | 71.7% | 2,940 | $135.2K | |||
| 20 | — | Sk Biopharmaceuticals Co Ltd | 2.08% | 73.8% | 2,220 | $121.7K | |||
| 21 | — | Biohaven Pharmaceutical Holding Co Ltd | 1.96% | 75.7% | 7,138 | $114.6K | |||
| 22 | S | Sarepta Therapeutics Inc | 1.89% | 77.6% | 5,760 | $110.5K | |||
| 23 | H | H. Lundbeck A/S (Class B) | 1.69% | 79.3% | 15,071 | $99.0K | |||
| 24 | T | Taysha Gene Therapies Inc | 1.47% | 80.8% | 13,541 | $86.4K | |||
| 25 | I | Idorsia, Ltd. | 1.40% | 82.2% | 10,071 | $82.0K | |||
| 26 | — | Bioarctic Ab | 1.40% | 83.6% | 2,419 | $81.7K | |||
| 27 | — | Neuren Pharmaceuticals Ltd. | 1.23% | 84.8% | 6,217 | $71.8K | |||
| 28 | I | Integra Lifesciences | 1.18% | 86.0% | 3,787 | $68.8K | |||
| 29 | C | Capricor Therapeutics Inc | 1.14% | 87.1% | 2,976 | $66.8K | |||
| 30 | R | Rapport Therapeutics, Inc. | 1.07% | 88.2% | 1,618 | $62.4K | |||
| 31 | S | Solid Biosciences Inc | 0.84% | 89.1% | 4,453 | $49.3K | |||
| 32 | A | Annexon Inc | 0.83% | 89.9% | 8,110 | $48.3K | |||
| 33 | A | Alto Neuroscience, Inc., Series C | 0.80% | 90.7% | 1,785 | $46.8K | |||
| 34 | M | Medincell Sa | 0.74% | 91.4% | 1,325 | $43.1K | |||
| 35 | R | Regenxbio Inc | 0.68% | 92.1% | 2,667 | $39.6K | |||
| 36 | L | Lb Pharmaceuticals Inc. | 0.67% | 92.8% | 1,182 | $39.5K | |||
| 37 | D | Dynavox Group Ab | 0.65% | 93.4% | 5,620 | $38.2K | |||
| 38 | R | Relmada Therapeutics Inc | 0.57% | 94.0% | 5,237 | $33.1K | |||
| 39 | D | Design Therapeutics Inc. | 0.54% | 94.5% | 2,146 | $31.9K | |||
| 40 | — | Bright Minds Biosciences Inc | 0.49% | 95.0% | 432 | $28.8K | |||
| 41 | C | Ceribell Inc | 0.47% | 95.5% | 1,395 | $27.6K | |||
| 42 | C | Clearpoint Neuro Inc | 0.47% | 96.0% | 1,514 | $27.3K | |||
| 43 | B | Brainsway Ltd | 0.46% | 96.4% | 1,684 | $27.0K | |||
| 44 | N | Neuropace Inc | 0.44% | 96.9% | 1,484 | $25.7K | |||
| 45 | — | Oncolys Biopharma Inc | 0.44% | 97.3% | 1,500 | $25.7K | |||
| 46 | B | Benitec Biopharma, Inc. | 0.43% | 97.7% | 1,906 | $25.2K | |||
| 47 | O | Ovid Therapeutics Inc | 0.43% | 98.2% | 9,627 | $25.1K | |||
| 48 | — | Prothena Corporation Public Limited Company Ordinary Shares | 0.43% | 98.6% | 2,650 | $25.2K | |||
| 49 | — | Microport Neurotech Ltd | 0.42% | 99.0% | 19,000 | $24.4K | |||
| 50 | N | Neurogene Inc - Series B | 0.40% | 99.4% | 714 | $23.2K | |||
| More holdings · Pro | |||||||||
IBRN ETF All Holdings
IBRN holdings total 80 positions. The top 10 holdings account for 42.9% of the fund, led by Alkermes Plc. Ordinary Shares at 4.7%, Scholar Rock Holding Corp Common Stock Usd 0.001 at 4.5%, Praxis Precision Medicines Inc Common Stock Usd.0001 at 4.5%.
IBRN portfolio concentration is moderate, with the top 10 representing 42.9% of total assets. The largest sector exposure is Health Care at 81.6%.
IBRN sectors provide a detailed breakdown. IBRN overlap shows how holdings compare to other funds in your portfolio.
IBRN ETF Holdings
80 of 80 holdings
- 1
Alkermes Plc. Ordinary Shares
ALKS:IEHealth Care4.69% - 2
Scholar Rock Holding Corp Common Stock Usd 0.001
SRRKUnknown4.55% - 3
Praxis Precision Medicines Inc Common Stock Usd.0001
PRAXHealth Care4.47% - 4
Ptc Therapeutics Inc
PTCTHealth Care4.38% - 5
Arrowhead Pharmaceuticals Inc
ARWRHealth Care4.31% - 6
Xenon Pharmaceuticals Inc. Common Shares
XENEHealth Care4.26% - 7
Acadia Pharmaceuticals Inc Common Stock Usd 0.0001
ACADHealth Care4.23% - 8
Dianthus Therapeutics Inc
DNTHHealth Care4.22% - 9
Biogen Inc. Com
BIIBHealth Care3.88% - 10
Neurocrine Biosciences Inc
NBIXHealth Care3.86% - 11
Axsome Therapeutics Inc
AXSMHealth Care3.80% - 12
Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
ARGX:ASHealth Care3.74% - 13
Denali Therapeutics Inc
DNLIHealth Care3.72% - 14
Carver Bancorp Inc.
CPRXHealth Care3.41% - 15
Blackrock Cash Funds: Treasury, Sl Agency Shares
XTSLAFinancials3.39% - 16
Edgewise Therapeutics Inc.
EWTXHealth Care3.05% - 17
Dyne Therapeutics Inc
DYNHealth Care2.93% - 18
Supernus Pharmaceuticals Inc
SUPNHealth Care2.50% - 19
Axogen Inc
AXGNHealth Care2.31% - 20
Sk Biopharmaceuticals Co Ltd
326030:KRUnknown2.08% - 21
Biohaven Pharmaceutical Holding Co Ltd
BHVN:VGHealth Care1.96% - 22
Sarepta Therapeutics Inc
SRPTHealth Care1.89% - 23
H. Lundbeck A/S (Class B)
HLUNB:COUnknown1.69% - 24
Taysha Gene Therapies Inc
TSHAHealth Care1.47% - 25
Idorsia, Ltd.
IDIA:SMUnknown1.40% - 26
Bioarctic Ab
BIOA.B:STUnknown1.40% - 27
Neuren Pharmaceuticals Ltd.
NEU:AUUnknown1.23% - 28
Integra Lifesciences
IARTHealth Care1.18% - 29
Capricor Therapeutics Inc
CAPRHealth Care1.14% - 30
Rapport Therapeutics, Inc.
RAPPHealth Care1.07% - 31
Solid Biosciences Inc
SLDBHealth Care0.84% - 32
Annexon Inc
ANNXHealth Care0.83% - 33
Alto Neuroscience, Inc., Series C
ANROHealth Care0.80% - 34
Medincell Sa
MEDCL:PAUnknown0.74% - 35
Regenxbio Inc
RGNXHealth Care0.68% - 36
Lb Pharmaceuticals Inc.
LBRXUnknown0.67% - 37
Dynavox Group Ab
DYVOX:STUnknown0.65% - 38
Relmada Therapeutics Inc Common Stock
RLMDHealth Care0.57% - 39
Design Therapeutics Inc.
DSGNHealth Care0.54% - 40
Bright Minds Biosciences Inc
DRUG:CAUnknown0.49% - 41
Ceribell Inc Common Stock Usd 0.001
CBLLHealth Care0.47% - 42
Clearpoint Neuro Inc
CLPTHealth Care0.47% - 43
Brainsway Ltd
BWAYUnknown0.46% - 44
Neuropace Inc Common Stock Usd 0.001
NPCEHealth Care0.44% - 45
Oncolys Biopharma Inc
4588:JPUnknown0.44% - 46
Benitec Biopharma, Inc.
BNTCHealth Care0.43% - 47
Ovid Therapeutics Inc
OVIDHealth Care0.43% - 48
Prothena Corporation Public Limited Company Ordinary Shares
PRTA:IEHealth Care0.43% - 49
Microport Neurotech Ltd
2172:SHUnknown0.42% - 50
Neurogene Inc - Series B
NGNEHealth Care0.40% - 51
Sanbio Co Ltd
4592:JPUnknown0.38% - 52
Vanda Pharmaceuticals Inc
VNDAHealth Care0.34% - 53
ZYLOX-TONBRIDGE MEDICAL TECH
2190:HKUnknown0.32% - 54
Newron Pharmaceuticals
NWRN:MIUnknown0.27% - 55
Maplight Therapeutics Inc
MPLTUnknown0.25% - 56
Peijia Medical Ltd
9996:KYUnknown0.24% - 57
Anavex Life Scienc Com New
AVXLHealth Care0.22% - 58
Santhera Pharmaceuticals
SANN:SMUnknown0.22% - 59
Inhibikase Therapeutics Inc
IKTUnknown0.19% - 60
Tonix Pharms. Hldg. Corp
TNXPHealth Care0.19% - 61
Voyager Therapeutics Inc
VYGRHealth Care0.17% - 62
Larimar Therapeutics Inc
LRMRHealth Care0.16% - 63
Ac Immune Sa
ACIUUnknown0.16% - 64
Acumen Pharmaceuticals, Inc. Series B
ABOSHealth Care0.15% - 65
Entrada Therapeutics Inc Common Stock Usd 0.0001
TRDAHealth Care0.15% - 66
Alector Inc
ALECHealth Care0.14% - 67
Neumora Therapeu
NMRAHealth Care0.12% - 68
Pepgen Inc
PEPGHealth Care0.11% - 69
Myung In Pharma Co Ltd
317450:KRUnknown0.09% - 70
Cognition Therap
CGTXHealth Care0.08% - 71
Sold TWD Bought USD 20251020
Other0.03% - 72
Iqvia, Inc. 2.25 01-15-2028
Other0.02% - 73
KRW CASH
Other0.01% - 74
Pimco Multisector Bond Active Exchange-Traded Fund Usetf 3.75% 18/12/2026
Other0.01% - 75
HKD CASH
Other0.00% - 76
Kardium Series D6 Cvt Pfd Stock Pp
Other0.00% - 77
ETD USD BALANCE WITH R30382
Other0.00% - 78
Telecom Italia Spa/Milano 0.00 04/01/2026
Other0.00% - 79
AUD Cash
Other0.00% - 80
Lakeside Community Development District Capital Improvement Revenue Bonds 5.75 05/01/2045
Other-3.37%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Alkermes Plc. Ordinary Shares | ALKS:IE | 4.690% | ||
| 2 | Scholar Rock Holding Corp Common Stock Usd 0.001 | SRRK | 4.550% | ||
| 3 | Praxis Precision Medicines Inc Common Stock Usd.0001 | PRAX | 4.470% | ||
| 4 | Ptc Therapeutics Inc | PTCT | 4.380% | ||
| 5 | Arrowhead Pharmaceuticals Inc | ARWR | 4.310% | ||
| 6 | Xenon Pharmaceuticals Inc. Common Shares | XENE | 4.260% | ||
| 7 | Acadia Pharmaceuticals Inc Common Stock Usd 0.0001 | ACAD | 4.230% | ||
| 8 | Dianthus Therapeutics Inc | DNTH | 4.220% | ||
| 9 | Biogen Inc. Com | BIIB | 3.880% | ||
| 10 | Neurocrine Biosciences Inc | NBIX | 3.860% | ||
| 11 | Axsome Therapeutics Inc | AXSM | 3.800% | ||
| 12 | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | ARGX:AS | 3.740% | ||
| 13 | Denali Therapeutics Inc | DNLI | 3.720% | ||
| 14 | Carver Bancorp Inc. | CPRX | 3.410% | ||
| 15 | Blackrock Cash Funds: Treasury, Sl Agency Shares | XTSLA | 3.390% | ||
| 16 | Edgewise Therapeutics Inc. | EWTX | 3.050% | ||
| 17 | Dyne Therapeutics Inc | DYN | 2.930% | ||
| 18 | Supernus Pharmaceuticals Inc | SUPN | 2.500% | ||
| 19 | Axogen Inc | AXGN | 2.310% | ||
| 20 | Sk Biopharmaceuticals Co Ltd | 326030:KR | 2.080% | ||
| 21 | Biohaven Pharmaceutical Holding Co Ltd | BHVN:VG | 1.960% | ||
| 22 | Sarepta Therapeutics Inc | SRPT | 1.890% | ||
| 23 | H. Lundbeck A/S (Class B) | HLUNB:CO | 1.690% | ||
| 24 | Taysha Gene Therapies Inc | TSHA | 1.470% | ||
| 25 | Idorsia, Ltd. | IDIA:SM | 1.400% | ||
| 26 | Bioarctic Ab | BIOA.B:ST | 1.400% | ||
| 27 | Neuren Pharmaceuticals Ltd. | NEU:AU | 1.230% | ||
| 28 | Integra Lifesciences | IART | 1.180% | ||
| 29 | Capricor Therapeutics Inc | CAPR | 1.140% | ||
| 30 | Rapport Therapeutics, Inc. | RAPP | 1.070% | ||
| 31 | Solid Biosciences Inc | SLDB | 0.840% | ||
| 32 | Annexon Inc | ANNX | 0.830% | ||
| 33 | Alto Neuroscience, Inc., Series C | ANRO | 0.800% | ||
| 34 | Medincell Sa | MEDCL:PA | 0.740% | ||
| 35 | Regenxbio Inc | RGNX | 0.680% | ||
| 36 | Lb Pharmaceuticals Inc. | LBRX | 0.670% | ||
| 37 | Dynavox Group Ab | DYVOX:ST | 0.650% | ||
| 38 | Relmada Therapeutics Inc Common Stock | RLMD | 0.570% | ||
| 39 | Design Therapeutics Inc. | DSGN | 0.540% | ||
| 40 | Bright Minds Biosciences Inc | DRUG:CA | 0.490% | ||
| 41 | Ceribell Inc Common Stock Usd 0.001 | CBLL | 0.470% | ||
| 42 | Clearpoint Neuro Inc | CLPT | 0.470% | ||
| 43 | Brainsway Ltd | BWAY | 0.460% | ||
| 44 | Neuropace Inc Common Stock Usd 0.001 | NPCE | 0.440% | ||
| 45 | Oncolys Biopharma Inc | 4588:JP | 0.440% | ||
| 46 | Benitec Biopharma, Inc. | BNTC | 0.430% | ||
| 47 | Ovid Therapeutics Inc | OVID | 0.430% | ||
| 48 | Prothena Corporation Public Limited Company Ordinary Shares | PRTA:IE | 0.430% | ||
| 49 | Microport Neurotech Ltd | 2172:SH | 0.420% | ||
| 50 | Neurogene Inc - Series B | NGNE | 0.400% | ||
| 51 | Sanbio Co Ltd | 4592:JP | 0.380% | ||
| 52 | Vanda Pharmaceuticals Inc | VNDA | 0.340% | ||
| 53 | ZYLOX-TONBRIDGE MEDICAL TECH | 2190:HK | 0.320% | ||
| 54 | Newron Pharmaceuticals | NWRN:MI | 0.270% | ||
| 55 | Maplight Therapeutics Inc | MPLT | 0.250% | ||
| 56 | Peijia Medical Ltd | 9996:KY | 0.240% | ||
| 57 | Anavex Life Scienc Com New | AVXL | 0.220% | ||
| 58 | Santhera Pharmaceuticals | SANN:SM | 0.220% | ||
| 59 | Inhibikase Therapeutics Inc | IKT | 0.190% | ||
| 60 | Tonix Pharms. Hldg. Corp | TNXP | 0.190% | ||
| 61 | Voyager Therapeutics Inc | VYGR | 0.170% | ||
| 62 | Larimar Therapeutics Inc | LRMR | 0.160% | ||
| 63 | Ac Immune Sa | ACIU | 0.160% | ||
| 64 | Acumen Pharmaceuticals, Inc. Series B | ABOS | 0.150% | ||
| 65 | Entrada Therapeutics Inc Common Stock Usd 0.0001 | TRDA | 0.150% | ||
| 66 | Alector Inc | ALEC | 0.140% | ||
| 67 | Neumora Therapeu | NMRA | 0.120% | ||
| 68 | Pepgen Inc | PEPG | 0.110% | ||
| 69 | Myung In Pharma Co Ltd | 317450:KR | 0.090% | ||
| 70 | Cognition Therap | CGTX | 0.080% | ||
| 71 | Sold TWD Bought USD 20251020 | - | 0.030% | ||
| 72 | Iqvia, Inc. 2.25 01-15-2028 | - | 0.020% | ||
| 73 | KRW CASH | - | 0.010% | ||
| 74 | Pimco Multisector Bond Active Exchange-Traded Fund Usetf 3.75% 18/12/2026 | - | 0.010% | ||
| 75 | HKD CASH | - | 0.000% | ||
| 76 | Kardium Series D6 Cvt Pfd Stock Pp | - | 0.000% | ||
| 77 | ETD USD BALANCE WITH R30382 | - | 0.000% | ||
| 78 | Telecom Italia Spa/Milano 0.00 04/01/2026 | - | 0.000% | ||
| 79 | AUD Cash | - | 0.000% | ||
| 80 | Lakeside Community Development District Capital Improvement Revenue Bonds 5.75 05/01/2045 | - | -3.370% |






































